Evidence map›Paper›PMID 38527842›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[Safety and efficacy of donor-derived chimeric antigen receptor T-cell therapy in patients with relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].

Y Q Zhuo, S F Tu, X Zhou, J L Yang, L J Zhou, R Huang, Y X Huang, M F Li, B Jin, B Wang and 6 more

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Y Q ZhuoDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
S F TuDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
X ZhouDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
J L YangDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
L J ZhouDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
R HuangDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Y X HuangDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
M F LiDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
B JinDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
B WangDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
S Q LiDepartment of Hematology, 920th Hospital of Joint Logistics Support Force of PLA, Kunming 650118, China.
Z T YuanDepartment of Hematology, 920th Hospital of Joint Logistics Support Force of PLA, Kunming 650118, China.
L H ZhangDepartment of Hematology, 920th Hospital of Joint Logistics Support Force of PLA, Kunming 650118, China.
L LiuDepartment of Hematology, 920th Hospital of Joint Logistics Support Force of PLA, Kunming 650118, China.
S B WangDepartment of Hematology, 920th Hospital of Joint Logistics Support Force of PLA, Kunming 650118, China.
Y H LiDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Zhujiang Hospital · CNSouthern Medical University · CN

Funding

Biomedical Major Project of Yunnan Province 202102AA100011Joint Funds of the National Natural Science Foundation of China U2001224National Natural Science Foundation of China 82270233, 82200246
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Burkitt LymphomaHematopoietic Stem Cell TransplantationPrecursor B-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaReceptors, Chimeric AntigenAntigens, CD19Cytokine Release SyndromeHumansImmunotherapy, AdoptivePathologic Complete ResponseRetrospective StudiesAntigens, CD19Receptors, Chimeric AntigenAllogeneic hematopoietic stem cell transplantationB-cell acute lymphoblastic leukemiaChimeric antigen receptorDonor-derivedRelapsed

Identifiers

PMID38527842
PMCPMC10951125
OpenAlexW4394767780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.